ArticleScientific reports2025
A novel unified Inception-U-Net hybrid gravitational optimization model (UIGO) incorporating automated medical image segmentation and feature selection for liver tumor detection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic accuracy and clinical performance of deep learning models for grading diabetic retinopathy: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Open dataset and deep learning model for intelligent diagnosis of neonatal respiratory distress syndrome and aspiration syndrome in newborns.Scientific reports · 2026Article
- Multimodal oral cancer detection with embedding-level oversampling of fused image and clinical data.Scientific reports · 2026Article
- Federated generative prompt learning with vision foundation models: universal efficient multi-center medical image analysis.NPJ digital medicine · 2026Article
- Microwave ablation and transcatheter arterial chemoembolization for hepatic epithelioid hemangioendothelioma two case reports with literature review.Discover oncology · 2026Article
- Advancing early detection of chromophobe renal cell carcinoma: a Bayesian optimization approach to machine learning models.Scientific reports · 2026Article
- Gastroenterological disease detection using transformer-based medical imaging for sustainable healthcare.Scientific reports · 2026Article
- WTAM-YOLO: a YOLOv11-based method for pulmonary nodule detection.Scientific reports · 2026Article
- A Systematic Review of Deep Learning Approaches for Hepatopancreatic Tumor Segmentation.Journal of imaging · 2026Review
- Comparing YOLO and U-net deep learning algorithms in chronic wound image segmentation.BMC medical imaging · 2026Article
- Artificial intelligence for precision oncology from phenotyping and drug discovery to clinical translation.Discover oncology · 2026Review
- A hybrid deep learning approach integrating CNN and transformer for lung cancer classification using CT scans.Scientific reports · 2026Article
- MicroRNAs as diagnostic prognostic and therapeutic biomarkers in glioblastoma.Discover oncology · 2026Review
- Optimized KNN with domain-informed features and LIME explainability for improved breast cancer classification.BMC medical informatics and decision making · 2026Article
- Integrative multi-omics analysis reveals an 11-gene malignant-myeloid interaction signature and identifies TPST1 as a potential regulator of immunosuppressive microenvironment in glioma.Discover oncology · 2026Article
- Survival prediction for bladder cancer using multimodal data with quantum neural networks and transformer architectures.Scientific reports · 2026Article
- Hybrid EfficientNet B4 and SVM framework for rapid and accurate bone cancer diagnosis from X-rays.Scientific reports · 2026Article
- Enhanced YOLO-based framework and benchmarking for automated Plasmodium vivax detection.Parasitology research · 2026Article
- Enhancing WSI image classification with graph convolutional neural networks and model uncertainty modeling.BMC medical imaging · 2026Article
- PatchSight-ImmuneMap-LifeSpan as a unified AI framework for breast cancer diagnosis, immune profiling and prognostic prediction.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Segmenting liver tumors in medical imaging is pivotal for precise diagnosis, treatment, and evaluating therapy outcomes. Even with modern imaging technologies, fully automated segmentation systems have not overcome the challenge posed by the diversity in the shape, size, and texture of liver tumors. Such delays often hinder clinicians from making timely and accurate decisions. This study tries to resolve these issues with the development of UIGO. This new deep learning model merges U-Net and Inception networks, incorporating advanced feature selection and optimization strategies. The goals of UIGO include achieving high precision segmented results while maintaining optimal computational requirements for efficiency in real-world clinical use. Publicly available liver tumor segmentation datasets were used for testing the model: LiTS (Liver Tumor Segmentation Challenge), CHAOS (Combined Healthy Abdominal Organ Segmentation), and 3D-IRCADb1 (3D-IRCAD liver dataset). With various tumor shapes and sizes ranging across different imaging modalities such as CT and MRI, these datasets ensured comprehensive testing of UIGO's performance in diverse clinical scenarios. The experimental outcomes show the effectiveness of UIGO with a segmentation accuracy of 99.93%, an AUC score of 99.89%, a Dice Coefficient of 0.997, and an IoU of 0.998. UIGO demonstrated higher performance than other contemporary liver tumor segmentation techniques, indicating the system's ability to enhance clinician's ability to deliver precise and prompt evaluations at a lower computational expense. This study underscores the effort towards advanced streamlined, dependable, and clinically useful devices for liver tumor segmentation in medical imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.